title: Response to comment on Home et al. Predictive and explanatory factors of change in HbA1c in a 24-week observational study of 66,726 people with type 2 diabetes starting insulin analogs. Diabetes Care 2014;37:1237-1245.
authors: Department of Diabetes, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K. philip.home@newcastle.ac.uk.
authors: Philip D
authors: PD
authors: Home
authors: Novo Nordisk International Operations A/S, Zürich, Switzerland.
authors: Chunduo
authors: C
authors: Shen
authors: Miracles, Diabetic Institute Pakistan, Lahore, Pakistan.
authors: Mohammad I
authors: MI
authors: Hasan
authors: Bangladesh Institute of Research & Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh.
authors: Zafar A
authors: ZA
authors: Latif
authors: Novo Nordisk International Operations A/S, Zürich, Switzerland.
authors: Jian-Wen
authors: JW
authors: Chen
authors: Instituto Jalisciense de Investigacion en Diabetes y Obesidad, Guadalajara, Mexico.
authors: Guillermo
authors: G
authors: González Gálvez
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male
chemical_list: D006442:Glycated Hemoglobin; D007328:Insulin